China and US-based XtalPi has raised $61 million this year from investors impressed its use of quantum physics, computational chemistry, and artificial intelligence to bring greater certainty to drug development
The average cost of taking a drug from molecule to marketing approval is just under $2.6 billion, according to the Tufts Center for the Study of Drug Development. The process is also fraught with risk...
Xyb2b.com, a B2B platform that helps Chinese e-commerce companies source products from overseas, has completed an extended Series B round of funding worth $100 million.
Beijing Ubox Online Technology, a Chinese vending machine manager, has received RMB1.6 billion ($226 million) in funding from Ant Financial Services Group and Primavera Capital Group.
CITIC Capital has scaled up for its latest China fund, raising 75% more capital than in the previous vintage. The buyout-focused GP expects tighter liquidity to drive more corporate carve-outs
Tala, a US financial technology provider looking to expand its microlending operations in India, has raised a $110 million Series D round from a group including PayPal Ventures.